PTPN22 and cancer: Epidemiological and cellular studies within the context of autoimmune diseases have illuminated the significance of protein tyrosine phosphatase nonreceptor type 22 (PTPN22) as a critical regulator of T cell receptor (TCR) signaling, pivotal in immune response modulation and cancer [6].